Valuation: Repligen Corporation

Market Cap 9.76B 8.5B 8.04B 7.31B 13.65B 935B 13.72B 95.81B 37.05B 475B 36.66B 35.84B 1,520B P/E 2026 *
229x
P/E 2027 * 100x
Enterprise Value 9.49B 8.27B 7.83B 7.11B 13.28B 909B 13.35B 93.21B 36.04B 462B 35.66B 34.87B 1,479B EV / Sales 2026 *
11.5x
EV / Sales 2027 * 9.56x
Free-Float
94.31%
Yield 2026 *
-
Yield 2027 * -
1 day+3.05%
1 week+8.20%
Current month-1.54%
1 month+5.41%
3 months+33.43%
6 months+49.40%
Current year+8.75%
1 week 162.1
Extreme 162.1
178.65
1 month 161.14
Extreme 161.1416
188.73
Current year 100.99
Extreme 100.99
188.73
1 year 100.99
Extreme 100.99
188.73
3 years 100.99
Extreme 100.99
211.13
5 years 100.99
Extreme 100.99
327.32
10 years 26.16
Extreme 26.16
327.32
Manager TitleAgeSince
Chief Executive Officer 56 2024-08-31
Director of Finance/CFO 52 2023-09-24
Chief Tech/Sci/R&D Officer - 2025-07-31
Director TitleAgeSince
Chairman 74 2011-12-13
Director/Board Member 60 2014-06-11
Director/Board Member 67 2015-09-30
Date Insider Type Main position Quantity % Market Cap. Importance
9/4/26 Sell

Chief Executive Officer

-3,035 0.0054%
9/1/26 Tax

Controller/Auditor

-277 0.0005%
8/20/26 Exercice

Chief Executive Officer

16,278 0.0288%
Change 5-day change 1-year change 3-year change Capi.($)
+3.05%+8.20%+49.25%+9.36% 9.76B
-0.13%-1.09%-23.81%+1.22% 177B
+0.18%+1.26%-1.91%+12.04% 118B
-2.85%-3.60%+7.03%+72.83% 60.78B
-0.26%+2.81%-3.30%-31.44% 49.53B
+1.18%-2.39%+4.57%+35.50% 48.29B
+0.68%+4.05%+15.03%-7.73% 32.96B
-2.64%-0.83% - - 28.94B
+1.27%+6.49%+42.85%-7.10% 25.48B
+1.13%+2.89%+11.87%-22.76% 21.77B
Average +0.16%+0.97%+11.29%+6.88% 57.31B
Weighted average by Cap. -0.17%-0.46%-3.00%+9.90%

Financials

2026 *2027 *
Net sales 827M 720M 682M 619M 1.16B 79.2B 1.16B 8.12B 3.14B 40.25B 3.11B 3.04B 129B 974M 849M 803M 730M 1.36B 93.32B 1.37B 9.57B 3.7B 47.43B 3.66B 3.58B 152B
Net income 41.92M 36.51M 34.56M 31.4M 58.66M 4.01B 58.95M 412M 159M 2.04B 157M 154M 6.53B 98.84M 86.09M 81.48M 74.03M 138M 9.47B 139M 970M 375M 4.81B 371M 363M 15.4B
Net Debt -265M -231M -218M -198M -371M -25.37B -372M -2.6B -1.01B -12.89B -995M -973M -41.27B -438M -382M -361M -328M -613M -41.95B -616M -4.3B -1.66B -21.32B -1.65B -1.61B -68.25B
Logo Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Employees
2,000
Date Price Change Volume
26-09-17 $178.19 +3.05% 1,086,011
26-09-16 $172.91 -1.04% 826,902
26-09-15 $174.73 +4.01% 891,264
26-09-14 $168.00 +1.71% 514,403
26-09-11 $165.18 +0.30% 944,558
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
172.91USD
Average target price
189.48USD
Spread / Average Target
+9.58%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RGEN Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!